SynbioTech to Present TWK10® Research and Microbiome CDMO Platform in the Emerging GLP-1 Companion-Nutrition Market at Vitafoods Asia 2026

---
SynbioTech to Present TWK10® Research and Microbiome CDMO Platform in the Emerging GLP-1 Companion-Nutrition Market at Vitafoods Asia 2026
Vote:
0 0
Previous Meet Whole Earth Allulose: the 100% natural sugar swap
Next Walovi Accelerates Global Push with WALOVI Singapore HQ Launch and Trio of Southeast Asia Deals

Related News

SynbioTech Brings Taiwan's Biotech Excellence to the Global Stage with TWK10® for Muscle Performance and Healthy Aging

SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver

SynbioTech's L. plantarum FS4722 Emerges as a Potential Preventive Approach for Hyperuricemia

TCI Biotech to Unveil New Vision at Vitafoods Europe 2025: CDMO+, High-Absorption Innovation, and 45 Years of Scientific Leadership

Vitafoods Asia 2025 Is Ready to Connect Nutraceutical World This September

Frost & Sullivan Explores the Rise of the "Healthspan Economy" and Emerging Growth Opportunities in Nutraceuticals

menu
menu